openPR Logo
Press release

Acquired Hemophilia Treatment Market Competitive And Growth Analysis 2024 | Pfizer Inc., Roche Holding AG , Bayer AG, Novartis AG, Bristol-Myers Squibb Company

Acquired Hemophilia Treatment Global Market Report 2024

Acquired Hemophilia Treatment Global Market Report 2024

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Acquired Hemophilia Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $14.88 billion In 2028 At A CAGR Of 5.1% :

The acquired hemophilia treatment market size has grown strongly in recent years. It will grow from $11.47 billion in 2023 to $12.2 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing ageing population, improved diagnostics and awareness, expanding patient pool, collaborative research initiatives, regulatory support and approvals..

The acquired hemophilia treatment market size is expected to see strong growth in the next few years. It will grow to $14.88 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to growing global population, rising healthcare investments, personalized medicine trends, international collaborations in research, increasing healthcare awareness, regulatory support for orphan drugs.. Major trends in the forecast period include enhanced monitoring and diagnostic technologies, collaboration for patient support programs, research on gene therapy approaches, increased utilization of immune tolerance induction, telemedicine for remote consultations..

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=13363&type=smp

Acquired Hemophilia Treatment Market Major Segments
The acquired hemophilia treatment market covered in this report is segmented -

1) By Treatment: On-Demand, Prophylaxis
2) By Type: Hemophilia A, Hemophilia B, Hemophilia C, Other Types
3) By End User: Hospitals, Clinic, Other End Users

Key Driver - Growing Number Of Clinical Trials Fuels Acquired Hemophilia Treatment Market Growth

A growing number of ongoing clinical trials is expected to propel the growth of the acquired hemophilia treatment market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Clinical trials assess the safety and efficacy of new treatments for acquired hemophilia, advancing research to improve patient outcomes and establish effective therapeutic interventions. For instance, in October 2023, according to ClinicalTrials.gov, a part of the National Institutes of Health (NIH), a US-based government agency responsible for conducting and supporting medical research, the number of registered studies increased from 437,523 in 2022 to 468,457 in all 50 states of the United States and across 221 countries. Moreover, it was reported that 143,613 studies (31% of the total) are registered in the U.S. only, while 251,159 studies (54% of the total) are registered in non-U.S. locations. Therefore, a growing number of ongoing clinical trials is driving the growth of the acquired hemophilia treatment market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=13363&type=smp

Prominent Trend - Expansion of Routine Prophylaxis Measures in Acquired Hemophilia Treatment Market

Major companies operating in the acquired hemophilia treatment market are focused on providing drugs with additional measures and getting them approved to sustain their position in the market. Drug approvals to include routine prophylaxis are increasing, mainly due to the need for more effective and safer. For instance, in June 2022, Chugai Pharmaceutical, a Japan-based drug manufacturer received extended approval from Japan's Ministry of Health, Labor and Welfare, to expand its use of Hemlibra (emicizumab) to include routine prophylaxis measures aimed at reducing or minimizing the occurrence of bleeds in individuals with acquired hemophilia A. Following this approval, additional measures to promptly manage and control bleeding shortly after diagnosis were allowed using Hemlibra, a bispecific antibody that binds simultaneously to two key targets, factor IX and factor X binding sites in the blood clotting process.

Acquired Hemophilia Treatment Market Players
Major companies operating in the acquired hemophilia treatment market report are Pfizer Inc., Roche Holding AG , Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Novo Nordisk A/S, Baxter Healthcare Corporation, Teva Pharmaceutical Industries Ltd., Mylan NV, Biogen Inc., CSL Limited , Grifols SA, Genentech Inc., Octapharma AG, Ferring Pharmaceuticals BV, Shire plc, BioMarin Pharmaceutical Inc., Sobi Inc., Kedrion Biopharma Inc., Chugai Pharmaceutical Co. Ltd., Spark Therapeutics Inc., Medexus Pharmaceuticals Inc., UniQure NV, Catalyst Biosciences Inc., Hema Biologics LLC, BioXcel Corporation

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/acquired-hemophilia-treatment-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the acquired hemophilia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acquired hemophilia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Acquired Hemophilia Treatment Market Report Structure
3. Acquired Hemophilia Treatment Market Trends And Strategies
4. Acquired Hemophilia Treatment Market - Macro Economic Scenario
5. Acquired Hemophilia Treatment Market Size And Growth
…..
27. Acquired Hemophilia Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acquired Hemophilia Treatment Market Competitive And Growth Analysis 2024 | Pfizer Inc., Roche Holding AG , Bayer AG, Novartis AG, Bristol-Myers Squibb Company here

News-ID: 3510359 • Views:

More Releases from The Business Research Company

Sports and Fitness Wear Market to Reach $89.94 Billion by 2028 with 6% CAGR Growth Driven By Sustainability and Innovation
Sports and Fitness Wear Market to Reach $89.94 Billion by 2028 with 6% CAGR Grow …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Sports And Fitness Wears Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $89.94 billion In
SAAS-Based HR Market to Reach $631 Billion by 2028 with a 13.9% CAGR Growth Driven By AI and Data Analytics
SAAS-Based HR Market to Reach $631 Billion by 2028 with a 13.9% CAGR Growth Driv …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. SAAS Based Human Resource Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $631.00 billion In
Cybersecurity Concerns Drive Expansion in Programming Software Market to $3.63 Billion with 15.5% CAGR Growth
Cybersecurity Concerns Drive Expansion in Programming Software Market to $3.63 B …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Programming Software Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $3.63 billion In 2028 At
Mobile-First and Hybrid Models Propel Online Language Learning Market to $39.42 Billion at 20.1% CAGR
Mobile-First and Hybrid Models Propel Online Language Learning Market to $39.42 …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Online Language Learning Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $39.42 billion In 2028

All 5 Releases


More Releases for Hemophilia

Hemophilia Market
Hemophilia is an inherited genetic syndrome which impairs body-2019s capability to control blood clotting or coagulation. The episodes of bleeding mainly depend on the severity of hemophilia issue. There are two major kinds of hemophilia namely Hemophilia A & Hemophilia B. Hemophilia A is considered to be five times more prevailing as compared to hemophilia B. Occurrence of hemophilia A is found in one out of five or six thousand
Hemophilia Therapeutics Pipeline Analysis Overview
The study analysed that the hemophilia pipeline comprises of 53 drug candidates in different stages of development. The pipeline analysis based on route of administration of active drug candidates showed, that around most of the hemophilia drug candidates are being developed to be administered by intravenous route. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/hemophilia-therapeutics-pipeline-analysis Most of the pharma and biotech companies are developing the therapeutics for hemophilia in collaboration with educational institutes. In
Hemophilia B - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Hemophilia B - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hemophilia B - Pipeline Review, H1 2017, provides an overview of the Hemophilia B (Hematological Disorders) pipeline landscape. Hemophilia B is a hereditary bleeding disorder caused by a lack of blood clotting factor IX. Symptoms include
Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate/Koval …
ReportsWorldwide has announced the addition of a new report title Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate/Kovaltry, Feiba), By Type of Hemophilia (Hemophilia A, Hemophilia B), By Treatment (On-Demand, Prophylaxis), By Therapy (Replacement , Immune Tolerance Induction ) Outlook 2022 to its growing collection of premium market research reports. Hemophilia is an inherited bleeding disorder that slows the blood clotting process. The people suffering from this condition experience prolonged
In-depth analysis of the Global Hemophilia Market: hemophilia A, hemophilia B, h …
Latest industry research report on: Global Hemophilia Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @ http://www.marketresearchreports.biz/sample/sample/1064504 The hemophilia market has entered into an era of unprecedented growth rate with a variety of treatment options. Development of new therapeutics along with expansion in the current treatment options has presented new opportunities to the market. Hemophilia being an inherited genetic bleeding disorder causes
Hemophilia Treatment Drugs Market Report 2024
Global Hemophilia Treatment Drugs Market: Overview The global hemophilia treatment drugs market is presently catering to various sub-types of hemophilia such as hemophilia A, hemophilia B and others such as acquired hemophilia and hemophilia C. The increasing awareness of this disorder and the introduction of innovative ways of managing this disease has opened up several opportunities for the global market in recent years. According to the research report, the global hemophilia